Authors


Justina Salib, BPS, PharmD Candidate 2022

Latest:

Vitamin D and COVID-19: An Evidence-Based Review

In this article, we will review the evidence describing a possible link between vitamin D and COVID-19.


David Caraway, MD, PhD

Latest:

Dismantle Stigmas, Stop the Blame, And Get Patients the Care They Need

There is a bias in this country against people whose medical condition is perceived to be the result of their own lifestyle choices. To combat stigma and its harmful effects, there needs to be broader understanding—even among medical professionals.


Louise Gagnon

Latest:

Digging into the Cause of Ocular Infections

The research points to the importance of isolating offending organism.


Deborah Adams Kaplan

Latest:

Some States Allowing Donation and Redistribution of Oncology Drugs

Collections of oncology drugs in 13 states are being redistributed to patients in need.


Daniel S. Streetman, PharmD

Latest:

OTC Drug Interaction Considerations in the Cough and Cold Aisle

OTC remedies are widely available, but some carry drug-drug or drug-disease interactions that pharmacists should be aware of.


Andrew J. Schuman, MD

Latest:

Technology Tools for Mental Health Screening

Online portals are accessible via tablet or computer and can streamline the mental health screening process.


Kenneth Bender, PharmD

Latest:

In the Fight Against Long COVID, Paxlovid Offers Limited Protection

The antiviral combination nirmatrelvir-ritonavir (Paxlovid) used for early symptoms of COVID-19 offers limited protection against the development of Long COVID.


Leah Kuntz

Latest:

Vistagen Enrolls First Phase 3 Trial Participant for Social Anxiety Disorder Drug Fasedienol

Vistagen has enrolled the first participant in the PALISADE-3 phase 3 trial of fasedienol for the treatment of social anxiety disorder.


Contagion Editorial Team

Latest:

Meningococcal ABCWY Vaccine Meets Endpoints in Trial

The vaccine, developed by GSK, is "very encouraging" step in fight to treat meningococcal disease


Ron Southwick

Latest:

Congress Members Urge Biden to Address Prior Authorizations in Medicare Advantage

A bipartisan group of 61 U.S. senators and 233 members of the U.S. House of Representatives signed onto a joint letter asking the Centers for Medicare & Medicaid Services to approve reforms.


Hiba Takieddin, PharmD

Latest:

A Primer on Atopic Dermatitis

Pharmacists can advise patients on how to control symptoms and reduce exacerbations.


Sarah Pitts, MD

Latest:

Impact of Hormonal Contraceptives on Adolescent Bone Health

Hormonal implants are generally thought to be safe for bone, although whether a young adolescent would reach their genetically determined PBM while using a contraceptive implant is not known.


Mostafa Kamal, CEO, Magellan Rx Management

Latest:

Drug Delivery: The Sky is Not the Limit

The use of drones to deliver critically important therapies can help overcome the barriers to care that impact patients in metropolitan areas.


Mark McCurdy, RPh

Latest:

Community Pharmacies Make Care Possible in Medical Deserts

Mark McCurdy, RPh, CPESN Nebraska Luminary, brings care to Mark's Pharmacy customers who lack easy access to basic, high-quality health-care services.


Aine Cryts

Latest:

Tips for Managing Autoimmune Disease During Pregnancy

Managing autoimmune conditions like type 1 diabetes, rheumatoid arthritis, and lupus during pregnancy can present challenges for patients and physicians.


Christine Blank

Latest:

Expanding Independent Pharmacy in Rural Health Care

The expansion from Express Scripts offers increased reimbursement opportunities and creates an Independent Pharmacy Advisory Committee to expand the role of rural, suburban and urban pharmacies in the healthcare system.


Joe Dysart

Latest:

New Video Marketing Tools

Ensuring your pharmacy’s video marketing dusts the competition has never been more important.


John Schieszer

Latest:

Medication Safety 2.0: Advances in Adherence Technology

From smart pills to augmented intelligence, technology has presented the health care industry with a host of options to improve medication adherence and safety.


Karen Appold

Latest:

3 Population Health Trends to Watch in 2022

Telehealth, efforts to address social determinants of health and a focus on health disparities are likely to be among the top priorities in population health this year.


Kayt Sukel

Latest:

Contemplating the Future of List Prices

What execs and experts think of the future of drug costs.


Lisa Holle, PharmD, BCOP, FHOPA

Latest:

Opinion: Pharmacists Are Best Suited to Improve Adherence

Learning a patient's specific situation might help overcome adherence barriers. 


Mari Edlin

Latest:

Solving the Drug Shortage Burden

Drug shortages might be decreasing, but their continued existence is urging the pharmacy industry to maintain its vigilance.


Mark Rowh

Latest:

Dealing with Difficult Colleagues

How you can manage these stereotypes found in the pharmacy workplace.


Tracey Walker

Latest:

Optimism for AI in Cancer Care

Oncologists recognize the potential of artificial intelligence (AI) in improving the quality of care and patient outcomes according to new research.


Frieda Wiley, PharmD

Latest:

Improving Health Care and Medication Access for Minority Populations

Across the country, minority populations face significant disparities in medication use. It's time for that to change.


Sylvia M. Cavero, PharmD

Latest:

Meropenem/Vaborbactam for Complicated UTIs

Vabomere combines a carbapenem and a beta-lactamase inhibitor as a treatment for complicated urinary tract infections.


Megan Elavsky, PharmD

Latest:

Urinary Incontinence: What Pharmacists Should Know

Up to 30% of the population is affected by the problem, this peer-reviewed article will give you the information you need.


Lisa M. Holle, PharmD, BCOP, FHOPA

Latest:

Melphalan Flufenamide for Relapsed or Refractory Multiple Myeloma

Melphalan flufenamide (Pepaxto; Oncopeptides AB) in combination with dexamethasone was granted accelerated approval on February 26, 2021, by the FDA for adult patients with relapsed or refractory multiple myeloma.


Gregory D. Greenier

Latest:

Atezolizumab for Urothelial Carcinoma and Non-Small Cell Lung Cancer

Here: an overview of atezolizumab, the first new drug in two decades for bladder cancer and now approved for NSCLC.


DeAnn Mullins, BPharm, CDE

Latest:

NCPA Embraces Value Over Volume

Greater accountability for pharmacy benefit managers? That's just one of the goals of the President of the National Community Pharmacists Association.

© 2024 MJH Life Sciences

All rights reserved.